Evaluation de l'effet thérapeutique des cellules souches mésenchymateuses dans la sclérodermie systémique

Abstract : Systemic sclerosis (SSc) is a rare intractable disease characterized by skin fibrosis and autoimmunity. Diffuse and rapidly progressive SSc (d-SSc) is associated with life-threatening involvements such as lung fibrosis, where there still is an unmet medical need. Displaying immunomodulatory and antifibrotic properties, mesenchymal stem cells (MSC) are an attractive cure for SSc. In this study, we aim at evaluating the therapeutic potential of MSC in a preclinical model of d-ScS.Patients and Methods: We evaluated the effects of MSC infusion in the murine model of ScS-HOCl, based on repeated injections of hypochlorite (HOCl). We compared several approaches using MSC in a preventive and curative approach, in syngeneic, allogeneic and xenogeneic settings, and using MSC isolated from adipose tissue (ASC) or bone marrow (BM-MSC).Results: ScS-HOCl is close to d-ScS phenotype, leading to skin and lung fibrosis, together with anti-topoisomerase 1 antibody production. We show beneficial effects of a preventive or curative injection of syngeneic MSCs, reducing tissue fibrosis. Fibrosis reduction following MSC treatment involves immunosuppressive effects, tissue remodeling via metalloprotease activation, and anti-oxydant activity. Similar benefits are observed in allogeneic and xenogeneic settings. ASC display greater immunosuppressive and remodeling capacities than BM-MSCs.Discussion and conclusion: Our study demonstrates the anti-fibrotic effects of MSCs in a relevant preclinical model of ScS, mimicking diffuse and rapidly progressive ScS. Pleiotropic capabilities of MSCs, combining anti-inflammatory, remodeling and antioxidant properties, are promising for future clinical applications in this disease.Keywords: systemic sclerosis, mesenchymal stem cells, HOCl
Document type :
Complete list of metadatas

Contributor : Abes Star <>
Submitted on : Friday, September 8, 2017 - 10:30:17 AM
Last modification on : Tuesday, May 28, 2019 - 10:42:01 AM


Version validated by the jury (STAR)


  • HAL Id : tel-01583956, version 1



Alexandre Maria. Evaluation de l'effet thérapeutique des cellules souches mésenchymateuses dans la sclérodermie systémique. Médecine humaine et pathologie. Université Montpellier, 2017. Français. ⟨NNT : 2017MONTT015⟩. ⟨tel-01583956⟩



Record views


Files downloads